Congress is warming up to psychedelics, especially when it comes to PTSD treatment. “I love the fact that there’s more interest, there’s more conversations, and we can ultimately help more people,” says KWC CEO Kevin Nicholson.
The U.S. Department of Veterans Affairs has launched clinical trials to study the effectiveness of psychedelic drugs including MDMA and psilocybin as a treatment for military veterans with post-traumatic stress disorder, addiction and other…
Interest is rising in the idea that ketamine, typically used as an anaesthetic (or as an illegal party drug), can help provide a lasting cure where traditional treatments, such as antidepressant drugs, have failed.
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis, or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only.